AvenovaTM as a Sterile Skin Preparation Agent

Completed · Early Phase 1

Conditions studied: Cleaning Product Causing Toxic Effect

In brief

Aim 1: To determine in vivo capability of AvenovaTM against common cutaneous microbial biome on human skin Aim 2: To compare to povidone-iodine 5% solution, 4% chlorhexidine and isopropyl alcohol against AvenovaTM as a sterile skin agent

Key facts

Study ID

NCT02990013

Run by

University of Miami

People needed

21

Starts

2018-12-01

Expected to finish

2019-12-20

Last updated by the study team

2020-02-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults age 18 and above able to provide informed consent to participate Adults attending Dr. Wendy Lee Oculoplastics Clinic

You may not qualify if…

• Adults unable to consent
• Individuals who less than 18 years of age
• Prisoners
• Pregnant women - while these cleansing agents are used on pregnant women as standard cleansing agents, effects to fetus unknown
• Patients currently using oral or topical antimicrobial agents
• History of skin infection to facial injectable of surgery
• Inability to tolerate cleansing procedure
• Inability to sit comfortably for 15 - 30 minutes

Where it is running

• University of Miami Bascom Palmer Eye Institute — Miami, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.